Top Wall Street analysts have revised their outlook on a number of top names in the market. For a comprehensive overview of all analyst rating changes, including upgrades and downgrades, please refer to our analyst ratings page.
In recent news, Goldman Sachs analyst Toshiya Hari upgraded Teradyne, Inc. (TER) from Neutral to Buy, with a price target increase from $118 to $161. Micron Technology, Inc. (MU) was also upgraded by Morgan Stanley analyst Joseph Moore from Underweight to Equal-Weight and raised the price target from $98 to $130. Globus Medical, Inc. (GMED) received an upgrade from Neutral to Overweight by Piper Sandler analyst Matt O’Brien along with an increase in the price target from $60 to $80. Jefferies analyst John Colantuoni upgraded MercadoLibre, Inc. (MELI) from Hold to Buy, setting a price target of $2,100 and Universal Health Services, Inc. (UHS) was upgraded by UBS analyst A.J. Rice from Neutral to Buy with a price target increase from $189 to $226.
